Essayer OR - Gratuit
What It Takes to Build Pharmaceutical Facilities That Perform from Day One
Express Pharma
|January 2026
As regulatory expectations tighten and speed-to-market pressures intensify, pharmaceutical facilities must be designed for certainty from day one. Drawing from large-scale project experience, engineering, simulation-led design, and early validation are redefining successful facility delivery
-
The pharmaceutical facility landscape has become increasingly complex. Regulatory expectations, operational efficiency, sustainability requirements, and speed-to-market pressures must all be addressed simultaneously. From my experience, the single biggest pitfall companies face when starting a major construction or expansion project is the lack of upfront integration.
Building a modern pharmaceutical facility is not just about civil construction. It requires the seamless integration of process design, utilities, automation, and regulatory compliance, including USFDA guidelines, cGMP, Annex 1, and other global regulatory frameworks. As I often say, “One of the biggest challenges in pharma projects is anticipating compliance and operational needs before the first brick is laid.” When integration is considered late in the process rather than from the very start, it leads to fragmented execution and costly rework.
Integration from Conceptualisation to Commissioning
At Pharma Access, we fundamentally change the traditional approach to designing and building pharmaceutical facilities through what we call Integration from the Ground Up.
We embed compliance and efficiency from the outset. By incorporating regulatory considerations into every phase of the project, from conceptualisation to commissioning, we ensure the final facility is not only compliant but also optimised for seamless, high-performance operation. This integrated approach reduces execution risk and enables smoother commissioning and validation.
Simulation-Based Engineering and Digital Twins
Our team relies heavily on Simulation-Based Engineering, because simulation is a powerful predictive tool.
Cette histoire est tirée de l'édition January 2026 de Express Pharma.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Listen
Translate
Change font size
